Invention Publication
- Patent Title: USES OF LABELED HSP90 INHIBITORS
-
Application No.: US18104037Application Date: 2023-01-31
-
Publication No.: US20240058482A1Publication Date: 2024-02-22
- Inventor: Gabriela Chiosis , Nagavarakishore Pillarsetty , Jason S. Lewis , Steven M. Larson , Tony Taldone , Mary L. Alpaugh , Erica M. Gomes-DaGama
- Applicant: Sloan-Kettering Institute for Cancer Research
- Applicant Address: US NY New York
- Assignee: Sloan-Kettering Institute for Cancer Research
- Current Assignee: Sloan-Kettering Institute for Cancer Research
- Current Assignee Address: US NY New York
- Main IPC: A61K51/04
- IPC: A61K51/04 ; A61K31/52 ; G01N33/50 ; G01N33/574
Abstract:
This invention concerns various methods of using labeled HSP90 inhibitors to improve treatment of cancer patients with HSP90 inhibitors, including ex vivo and in vivo methods for determining whether a tumor will likely respond to therapy with an HSP90 inhibitor.
Public/Granted literature
- US2130713A Air brake Public/Granted day:1938-09-20
Information query
